Neuroimaging Insights Into the Neurophysiological Subtypes of Major Depressive Disorder
Xiaoyi Sun1, Yong He2, Mingrui Xia3
1State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China; Beijing Key Laboratory of Brain Imaging and Connectomics, Beijing Normal University, Beijing, China; International Data Group/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China; School of Systems Science, Beijing Normal University, Beijing, China; Department of Biomedical Engineering, College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.
Neuroimaging reveals distinct subtypes of major depressive disorder (MDD), moving beyond symptom-based diagnosis. This approach advances precision psychiatry by identifying individualized brain patterns for better treatment selection.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Major depressive disorder (MDD) is characterized by significant heterogeneity, complicating diagnosis and treatment.
- Current diagnostic methods based on symptoms lack reliability due to this heterogeneity.
- Neuroimaging-based subtyping offers a promising avenue for precision psychiatry in MDD.
Purpose of the Study:
- To critically synthesize neuroimaging-based subtyping research in MDD.
- To integrate recent methodological advancements in subtyping.
- To evaluate the clinical translation and future directions for neuroimaging in MDD.
Main Methods:
- Integration of advanced machine learning techniques like unsupervised/semi-supervised clustering and deep learning.
- Application of normative modeling for individualized deviation profiles.
- Comparative analysis across functional, structural, diffusion, and multimodal neuroimaging data.
Main Results:
- Identification of convergent and divergent subtype patterns across various imaging modalities.
- Evidence linking neuroimaging subtypes to symptom dimensions, illness trajectories, and treatment responses.
- Development of a translational framework for clinical implementation of neuroimaging subtypes.
Conclusions:
- Neuroimaging subtyping offers a powerful tool to address MDD heterogeneity.
- Further research requires large-scale harmonized datasets and multimodal data integration.
- Translating brain-based heterogeneity into clinical practice is crucial for advancing MDD treatment.
More Related Videos
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
08:42Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Depressive Disorders: MDD and Dysthymia
Depression: Overview
